Due to the role of cyclin D1 overexpression and PARP down expression in the sustenance of cancerous cells and their relationship with AKT 1 and p110α, inhibiting AKT 1 and p110α leads to augmented radiosensitivity in triple-negative breast cancer cells (20, 22). Here, CCND1 is linked to triple-negative breast carcinoma.